Medical Device Network on MSN1d
Medtronic announces two-year trial outcomes of Evolut TAVR
Medtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial’s two-year ...
MassDevice1d
Medtronic has positive TAVR results in small aortic annulus patients
Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...
Medtronic releases two-year results of SMART trial for TAVR
Medtronic (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN, SMART, Trial, the largest international ...
Zacks Investment Research on MSN1d
Positive Trial Data on Evolut TAVR Likely to Support MDT Stock
Medtronic plc MDT recently unveiled two-year Small Annuli Randomized to Evolut or SAPIEN (“SMART”) Trial results at the Cardiovascular Research Technologies (“CRT”) 2025 conference in Washington, D.C.
BioWorld1d
Medtronic sees SMART TAVR results in small aortic annulus patients
Medtronic plc released positive results from a two-year trial of Evolut TAVR that demonstrated superior valve performance in patients with small aortic annuli. The SMall Annuli Randomized To Evolut or ...
Nasdaq2d
Medtronic : Data Confirms Superior Valve Performance Of Evolut TAVR System In Small Annulus Patients
(RTTNews) - Medtronic plc (MDT ... comparative trial of transfemoral transcatheter aortic valve replacement (TAVR). In patients with aortic stenosis and a small aortic annulus, results showed ...
Medscape4d
Asymptomatic Aortic Stenosis: “Time to Act” or Not So Fast?
Early surgical or transcatheter aortic valve replacement is not typically recommended for severe aortic stenosis in the ...
PharmiWeb1d
SMART Trial two-year data continues to demonstrate…
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...
Morningstar2d
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
Additional results demonstrated that Evolut TAVR showed the following relative ... which is part of the Cardiovascular Portfolio at Medtronic. "At two years, we continue to see superior valve ...
Yahoo Finance11d
Medtronic partners with Brainomix on AI stroke tool
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medtronic has struck a deal to accelerate adoption of ...
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...
Medindia3d
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR system in small annulus patients
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMa ...